National Health Act (Pharmaceutical Benefits – Early Supply) Amendment March 2010 specification under subsection 84AAA(2) (No. PB 11 of 2010) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 11 of 2010
National Health (Pharmaceutical Benefits – Early Supply) Amendment March 2010 - Specification Under Subsection 84AAA(2)
Amendment determination under subsection 84AAA(2) of the National Health Act 1953
I, Felicity McNeill, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 22 February 2010
FELICITY MCNEILL
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination — Pharmaceutical Benefits - Early Supply
1 Name of Instrument
(1) This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment March 2010 - specification under subsection 84AAA(2).
(2) This Instrument may also be cited as “No. PB 11 of 2010”.
2 Commencement
This Instrument commences on 1 March 2010.
3 Amendment of PB 30 of 2009
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.
Schedule 1 Amendments
Schedule 1, after item dealing with Candesartan with hydrochlorothiazide, Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg
insert in the columns in the order indicated:
| Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg | Oral | 30 | 5 |
| Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg | Oral | 30 | 5 |
Schedule 1, after item dealing with Gemfibrozil
insert in the columns in the order indicated:
| Gliclazide | Tablet 60 mg (modified release) | Oral | 60 | 5 |
Schedule 1, after item dealing with Moxonidine
insert in the columns in the order indicated:
| Nebivolol | Tablet 1.25 mg (as hydrochloride), 28 | Oral | 1 | 5 |
| Tablet 1.25 mg (as hydrochloride) | Oral | 56 | 5 | |
| Tablet 5 mg (as hydrochloride) | Oral | 28 | 5 | |
| Tablet 10 mg (as hydrochloride) | Oral | 28 | 5 |
0
0
0